IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q4 2024 Holdings

Filed 2025-02-18 | 12 holdings | $26.9M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2025-02-18) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)ACOM09062X103$16.7M108,92361.9%
Biontech SE(BNTX)ACOM09075V102$10.1M88,66337.6%
United Therapeutics Corp(UTHR)ACOM91307C102$32.5K92,0570.1%
Exelixis Inc(EXEL)ACOM30161Q104$32.2K965,8660.1%
Cardinal Health Inc(CAH)ACOM14149Y108$24.7K208,8450.1%
Jazz Pharmaceuticals PLC(JAZZ)ACOMG50871105$13.0K105,8030.0%
Enanta Pharmaceuticals Inc(ENTA)ACOM29251M106$12.2K2,117,3900.0%
Indivior PLC(INDV)ACOMG4766E116$11.6K935,6800.0%
Sanofi(SNY)ACOM80105N105$7.2K149,1960.0%
Alkermes PLC(ALKS)ACOMG01767105$6.8K238,1360.0%
Vanda Pharmaceuticals Inc(VNDA)ACOM921659108$1.8K378,7620.0%
Mural Oncology PLCACOMG63365103$22670,1630.0%